Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study

2015 ◽  
Vol 25 (4) ◽  
pp. 503-513 ◽  
Author(s):  
Eiichi Tanaka ◽  
Eisuke Inoue ◽  
Daisuke Hoshi ◽  
Yoko Shimizu ◽  
Akiko Kobayashi ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document